id=1164  Browse230   Market Data Tables45    Figures280   Pages and in-depth TOC on "Digital X-ray Market - Global Forecast to 2026”Some of the prominent key players are:Siemens Healthineers (Germany),GE Healthcare (US),Koninklijke Philips N. Based on portability, the digital X-ray market is segmented into fixed digital X-ray systems and portable digital X-ray systems. Fixed digital X-ray systems include floor-to-ceiling-mounted systems and ceiling-mounted systems, while portable digital X-ray systems include mobile X-ray systems and handheld X-ray systems. The global digital X-ray systems market is divided into new and retrofit digital X-ray systems. Based on applications, the digital X-ray market is segmented into general radiography, dental applications, fluoroscopy, cancer, and mammography applications.

DRIVERS                    1. 4 Growing patient volume due to global outbreak of COVID-19                    1. RESTRAINTS                    2. OPPORTUNITIES                    3. CHALLENGES                    4.

By outsourcing the development and production of antibodies and reagents, companies can reduce costs, increase efficiency, access expertise, and increase flexibility, thus creating opportunities in the research antibodies and reagents market. The report Research Antibodies & Reagents Market are projected to reach USD 16. TrendsIncreasing research on therapeutic antibodiesRecombinant antibodies supporting the smooth transition from in vitro to in vivoGrowing consolidation of the life sciences market for antibodies and reagentsMarket Segmentation: -On the basis of the product, the research antibodies and reagents market are segmented into reagents and antibodies. The monoclonal antibodies segment accounted for the largest share of the research antibodies market by form in 2022. On the basis of application, the research antibodies and reagents market are segmented into proteomics, drug development and Genomics.

The report Infusion Pump Market size is 17. id=90374506KEY MARKET DYNAMICS          1 MARKET DRIVERS                   1 Rising demand for ambulatory infusion pumps in home care settings                   2 Increasing incidence of chronic diseases along with rapid growth in geriatric population                   3 Growing number of surgical procedures performed               2 MARKET RESTRAINTS                   1 Product recalls                   2 Stringent regulatory requirements for new products                   3 Increasing adoption of refurbished and rental infusion pumps          3 MARKET OPPORTUNITIES                   1 High growth opportunities in emerging countries                   2 Growing adoption of specialty infusion systems          4 MARKET CHALLENGES                   1 Increasing incidence of medication errors and lack of wireless connectivity in most hospitals              Market Segmentation:In 2022, the market for dedicated accessories and consumables accounted for the largest share and was also the faster growing segment of the infusion pump accessories and consumables market. Out of the dedicated accessories and consumables market in 2022, the volumetric infusion pump accessories and consumables segment accounted for the largest share. Regional AnalysisThe infusion pump market is segmented into five major regions, namely, Europe, North America, Latin America, the Middle East and Africa, and Asia Pacific (APAC). id=90374506Top Key Players:The key players in the infusion pump market Becton, Dickinson and Company (US), Baxter International, Inc.

id=144536297  Browse126  Market Data Tables32   Figures170  Pages and in-depth TOC on " Bioimpedance Analyzers Market - Global Forecast to 2028”Some of the prominent key players are:OMRON Corporation (Japan),Tanita Corporation (Japan),InBody (South Korea),RJL Systems (US), seca GmbH & Co. The bioimpedance analyzers market, by product, has been segmented into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. By usage type, the global bioimpedance analyzers market is broadly segmented into into consumer-grade and professional-grade bioimpedance analyzers. Based on application, the bioimpedance analyzers market is segmented into segmental body measurement and whole-body measurement. Based on the region, the bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

id=87857774Based on component, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into software, services, and wearable, mobile & other devices. The hybrid model is the fastest growing in Electronic Clinical Outcome Assessment (eCOA) Solutions market in 2023 attributing to its ability to offer a balanced and flexible approach to data collection in clinical trials. Based on application, the Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into clinical trials, observational studies and real-world evidence (RWE) generation, patient management and registries, and other applications. The Electronic Clinical Outcome Assessment (eCOA) Solutions market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2023, North America accounted for the largest share of the Electronic Clinical Outcome Assessment (eCOA) Solutions market.

Based on the product, the image-guided radiation therapy market is segmented into LINAC (linear accelerator), 4D gating/ 4D RT, PET/ MRI-guided radiation therapy, CT scanning, and portal imaging.  Intensity modulation radiation therapy procedure segment accounted for the largest share of the image-guided radiation therapy market in 2022-2028. Based on the procedure, the image-guided radiation therapy market is segmented into 3D conformal therapy, stereotactic therapy, proton beam therapy, intensity modulation radiation therapy, and particle therapy. 2% market share of the image-guided radiation therapy market in 2022. Hospitals segment to register for the largest market share of the image-guided radiation therapy market in 2022-2028.

The growth of Endoscopic Retrograde Cholangiopancreatography Market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries. On the other hand, the high costs of endoscopic retrograde cholangiopancreatography devices, the development of other procedures like EUS and MRCP, and the shortage of trained physicians and endoscopists are factors expected to restrain the market growth to a certain extent. The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2. id=170242954Top Key Players:The major players in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B.

id=605  Browse182   Market Data Tables44    Figures245   Pages and in-depth TOC on "Preimplantation Genetic Testing Market - Global Forecast to 2028”Some of the prominent key players are:Illumina, Inc. Based on the products, the global preimplantation genetic testing market is broadly segmented into instruments, reagents & consumables, and software & services. By end user, the global preimplantation genetic testing market is broadly segmented into hospitals, diagnostic labs, fertility clinics, and other end users. Based on the region, the preimplantation genetic testing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. On the other hand, socio-ethical concerns surrounding preimplantation genetic testing may challenge the growth of market.

The isothermal nucleic acid amplification technology market is expected to grow at a CAGR of 9. KEY MARKET DYNAMICS           1 DRIVERS                   1 Recent launches of INAAT consumables by prominent market players                   2 Growing funding initiatives for molecular diagnostics & infectious disease diagnostics                   3 High prevalence of infectious diseases          2 RESTRAINTS                   1 Unfavorable reimbursement scenario for in vitro diagnostic tests          3 OPPORTUNITIES                   1 INAAT tests as point-of-care tools                   2 Start-ups focusing on INAAT          4 CHALLENGES                   1 Dominance of PCRDownload PDF Brochure: - https://www. id=839Market Segmentation ·        Based on the product, the INAAT market is segmented into assay, kits, and reagents, and systems. id=839Recent Developments·        In May 2022, Hologic, Inc. the market was poised for growth globally, with increasing applications in infectious disease diagnostics, point-of-care testing, and environmental monitoring.

The global Hollow fiber filtration market is projected to reach USD 597 million by 2026 from USD 303 million in 2021, at a CAGR of 14. This acquisition helped expand the company’s offerings in the hollow fiber filtration market. This acquisition strengthened Danaher’s position in the hollow fiber filtration market. id=267011039Top Key Players:Prominent players in the Hollow Fiber Filtration Market are Repligen Corporation (US), Danaher (US), Asahi Kasei Corporation (Japan), Parker-Hannifin Corp (US), Sartorius Stedim Biotech S. The hollow fiber filtration market is expected to continue evolving, driven by advancements in technology, changes in industry regulations, and the increasing need for efficient and sustainable filtration solutions.

The growth of Benign Prostatic Hyperplasia Treatment Market is driven by the increasing prevalence of benign prostatic hyperplasia, the rising preference for minimally invasive surgeries, increasing obesity rate, and investments, funds, and grants for research in the field of BPH treatment. The Benign prostatic hyperplasia treatment market is projected to reach USD 14. id=198000374 Market Segmentation: -Based on the type, the BPH treatment market is segmented into drug treatment and surgical treatment. In 2019, North America commanded the largest share of the benign prostatic hyperplasia treatment market. id=198000374 Recent Developments·        In 2021, In January 2021, PHAREX Health Corporation in partnership with the Philippine Urological Association (PUA), launched Pharex Tamsulosin for BPH treatment.

The report Infusion Pump Market size is 17. id=90374506KEY MARKET DYNAMICS          1 MARKET DRIVERS                   1 Rising demand for ambulatory infusion pumps in home care settings                   2 Increasing incidence of chronic diseases along with rapid growth in geriatric population                   3 Growing number of surgical procedures performed               2 MARKET RESTRAINTS                   1 Product recalls                   2 Stringent regulatory requirements for new products                   3 Increasing adoption of refurbished and rental infusion pumps          3 MARKET OPPORTUNITIES                   1 High growth opportunities in emerging countries                   2 Growing adoption of specialty infusion systems          4 MARKET CHALLENGES                   1 Increasing incidence of medication errors and lack of wireless connectivity in most hospitals              Market Segmentation:In 2022, the market for dedicated accessories and consumables accounted for the largest share and was also the faster growing segment of the infusion pump accessories and consumables market. Out of the dedicated accessories and consumables market in 2022, the volumetric infusion pump accessories and consumables segment accounted for the largest share. Regional AnalysisThe infusion pump market is segmented into five major regions, namely, Europe, North America, Latin America, the Middle East and Africa, and Asia Pacific (APAC). id=90374506Top Key Players:The key players in the infusion pump market Becton, Dickinson and Company (US), Baxter International, Inc.

id=1279  Browse150   Market Data Tables65    Figures350   Pages and in-depth TOC on " Hemodialysis and Peritoneal Dialysis Market - Global Forecast to 2029”Some of the prominent key players are:Fresenius Medical Care AG & Co. id=1279The hemodialysis market is segmented based on product and service. The hemodialysis services segment is anticipated to grow at significant rate during the forecast period. Based on end users, home care setting is expected to grow at a significant rate owing to growing preference of patients for home hemodialysis modality, technological advancements, and the cost-effectiveness of home dialysis treatment over incentre dialysis procedures. On the basis of region, the hemodialysis and peritoneal dialysis market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa.

The report Respiratory Diagnostics Market is expected to reach USD 8. id=163390459  Browse83    Market Data Tables45    Figures146   Pages and in-depth TOC on "Respiratory Diagnostics Market - Global Forecast to 2029”Some of the prominent key players are:Koninklijke Philips N. Hospitals and clinics are increasingly integrating respiratory diagnostics into routine care protocols. In 2022, North America held the largest market share for respiratory diagnostics market. The growing awareness of the significance of early detection and effective management of respiratory diseases has emerged as a significant factor propelling the utilization of respiratory diagnostics products and services in North America.

The global Animal growth promoters and performance enhancers market is projected to reach USD 21. id=137134167MARKET DYNAMICS           1 DRIVERS                    1. 3 Rise in the global demand for naturally produced growth promoters                    1. 4 Rise in awareness about growth promoters                    1. 5 Rise in animal epidemics and climate change           2 RESTRAINTS                    2.